NCT02177994View on ClinicalTrials.gov

Antibiotic Prophylaxis for Elective Cesarean Section

PHASE3CompletedINTERVENTIONAL
Enrollment

328

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

November 30, 2014

Conditions
Infection of Cesarian Section Wound Following Delivery
Interventions
DRUG

ceftriaxone 1gm for intravenous infusion

Patients undergoing elective cesarean section with Gestational age 37 weeks or more. comparing the effect of administration of 1 gm ceftriaxone in elective cesarean section 30-60 min before skin incision versus after cord clamping.on post-cesarean section infection(wound infection as a primary outcome)

Trial Locations (1)

+20

Antibiotic Prophylaxis for Elective Cesarean Section, Cairo

All Listed Sponsors
lead

Ain Shams Maternity Hospital

OTHER

NCT02177994 - Antibiotic Prophylaxis for Elective Cesarean Section | Biotech Hunter | Biotech Hunter